ArticleActa pharmaceutica Sinica. B2024

DNMT3A loss drives a HIF-1-dependent synthetic lethality to HDAC6 inhibition in non-small cell lung cancer.

Jiayu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.